Yusheng Han

CIK: 0001843554

Transaction Breakdown

Open Market Buys (P)8 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNR

Burning Rock Biotech Ltd

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BNR
Burning Rock Biotech Ltd
Jun 26, 2026
Purchase(P)
Direct
24.9K shares at avg. $8.00$199K
BNR
Burning Rock Biotech Ltd
Jun 24, 2026
Purchase(P)
Direct
250K shares at avg. $8.00$2.0M
BNR
Burning Rock Biotech Ltd
Jun 23, 2026
Purchase(P)
Direct
6K shares at avg. $7.50$45K
BNR
Burning Rock Biotech Ltd
Jun 22, 2026
Purchase(P)
Direct
104.7K shares at avg. $7.45$780K
BNR
Burning Rock Biotech Ltd
Jun 16, 2026
Purchase(P)
Direct
111.1K shares at avg. $9.00$1000K
BNR
Burning Rock Biotech Ltd
Jun 12, 2026
Purchase(P)
Direct
210K shares at avg. $9.25$1.9M
BNR
Burning Rock Biotech Ltd
Jun 11, 2026
Purchase(P)
Direct
24.8K shares at avg. $8.74$216K
BNR
Burning Rock Biotech Ltd
Mar 31, 2026
Purchase(P)
Direct
314.9K shares at avg. $17.36$5.5M

		Type	Shares	Price		Ownership
Jun 26, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	24,900	$8.00	$199,090	Direct
Jun 24, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	250,000	$8.00	$2,000,000	Direct
Jun 23, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	5,990	$7.50	$44,920	Direct
Jun 22, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	104,650	$7.45	$779,674	Direct
Jun 16, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	111,110	$9.00	$999,957	Direct
Jun 12, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	210,000	$9.25	$1,942,143	Direct
Jun 11, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	24,760	$8.74	$216,388	Direct
Mar 31, 2026	BNR Burning Rock Biotech Ltd	Purchase(P)	314,870	$17.36	$5,466,143	Direct

1-8 of 8 transactions

About Han Yusheng

Han Yusheng (SEC CIK 0001843554) files insider reports with the SEC as Director of Burning Rock Biotech Ltd (BNR).

Signal8 holds 3 ownership filings by Han Yusheng (1 Form 3, 2 Form 4), filed between Mar 17, 2026 and Jul 2, 2026. Those filings report 8 transactions, from Mar 31, 2026 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Han Yusheng's filings is in SHANGHAI.

Recent filings by Han Yusheng

Jun 26, 2026: Open-market purchase of BNR shares (Form 4, code P).
Jun 24, 2026: Open-market purchase of BNR shares (Form 4, code P).
Jun 23, 2026: Open-market purchase of BNR shares (Form 4, code P).
Jun 22, 2026: Open-market purchase of BNR shares (Form 4, code P).
Jun 16, 2026: Open-market purchase of BNR shares (Form 4, code P).

Other insiders filing for Burning Rock Biotech Ltd (BNR)

DENG FENG, Director
Hayes Wendy W., Director
Zhang Zhihong, Director
Hu Xiaozhi, Senior Director in Finance
Xu Licen Lisa, Director

How to read Form 4 transaction codes